Abselion is delighted to announce the appointment of Kim Orton-Smith as Vice President of Sales & Marketing. Kim brings 19 years of global commercial experience in life sciences, with a track record of turning product innovation into scalable revenues and driving sustainable commercial strategies.
Prior to joining Abselion, Kim held leadership roles at Abcam, where she played a pivotal role in business growth, product innovation, and customer acquisition. As Vice President of Product (Research Area Strategy), she led a strategic transformation that expanded market reach, accelerated product adoption, and drove year-on-year revenue growth in a competitive landscape. She has successfully developed high-performing, international teams by fostering customer-centric strategies and a results-driven culture.
Kim has extensive experience in go-to-market strategies, business development, and strategic partnerships. She has collaborated with industry leaders to develop and validate unique antibodies and antibody-based assay platforms, demonstrating her expertise in aligning commercial vision with scientific excellence.
“I am thrilled to welcome Kim to the Abselion team. As we scale our commercial efforts, Kim’s expertise in sales, marketing, and business strategy will be instrumental in expanding our reach and delivering value to our customers.” – Ruizhi Wang, CEO
“Abselion is at the forefront of innovation in protein quantification, and I’m excited to join a team dedicated to simplifying workflows for scientists developing next-generation biotherapeutics. I look forward to driving commercial success and contributing to Abselion’s growth.” – Kim Orton-Smith, VP of Sales & Marketing
Please join us in welcoming Kim to Abselion!